The oriented development of antituberculotics (Part II): halogenated 3-(4-alkylphenyl)-1,3-benzoxazine-2,4-(3H)-diones. 2007

Karel Waisser, and Josef Matyk, and Hana Divisová, and Petra Husáková, and Jirí Kunes, and Vera Klimesová, and Karel Palát, and Jarmila Kaustová
Department of Inorganic and Organic Chemistry, Charles University in Prague, Faculty of Pharmacy in Hradec Králové, Heyrovského, Czech Republic. waisser@faf.cuni.cz

Based on our previous studies, 21 new halogenated 3-(4-alkylphenyl)-1,3-benzoxazine-2,4-(3H)-diones were synthesized by the reaction of salicylanilides and methyl-chloroformate. All compounds were screened in vitro against three different strains of mycobacterium, and Free-Wilson method was used to establish structure-activity relationships. 6-Bromo-3-(4-butylphenyl)-1,3-benzoxazine-2,4-(3H)-dione 3b proved to be the most active compound of the series.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009161 Mycobacterium A genus of gram-positive, aerobic bacteria. Most species are free-living in soil and water, but the major habitat for some is the diseased tissue of warm-blooded hosts. Mycobacteria
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D010078 Oxazines Six-membered heterocycles containing an oxygen and a nitrogen.
D010636 Phenols Benzene derivatives that include one or more hydroxyl groups attached to the ring structure.
D004149 Dioxoles
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D012458 Salicylanilides 2-Hydroxy-N-phenylbenzamides. N-phenyl substituted salicylamides. Derivatives have been used as fungicides, anti-mildew agents and topical antifungal agents. In concentrated form may cause irritation of skin and mucous membranes. N-Phenylsalicylamides,N Phenylsalicylamides
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Karel Waisser, and Josef Matyk, and Hana Divisová, and Petra Husáková, and Jirí Kunes, and Vera Klimesová, and Karel Palát, and Jarmila Kaustová
February 2003, Die Pharmazie,
Karel Waisser, and Josef Matyk, and Hana Divisová, and Petra Husáková, and Jirí Kunes, and Vera Klimesová, and Karel Palát, and Jarmila Kaustová
May 2001, Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti,
Karel Waisser, and Josef Matyk, and Hana Divisová, and Petra Husáková, and Jirí Kunes, and Vera Klimesová, and Karel Palát, and Jarmila Kaustová
March 1963, Journal of medicinal chemistry,
Karel Waisser, and Josef Matyk, and Hana Divisová, and Petra Husáková, and Jirí Kunes, and Vera Klimesová, and Karel Palát, and Jarmila Kaustová
January 2002, Folia microbiologica,
Karel Waisser, and Josef Matyk, and Hana Divisová, and Petra Husáková, and Jirí Kunes, and Vera Klimesová, and Karel Palát, and Jarmila Kaustová
November 2003, Farmaco (Societa chimica italiana : 1989),
Karel Waisser, and Josef Matyk, and Hana Divisová, and Petra Husáková, and Jirí Kunes, and Vera Klimesová, and Karel Palát, and Jarmila Kaustová
October 2001, Farmaco (Societa chimica italiana : 1989),
Karel Waisser, and Josef Matyk, and Hana Divisová, and Petra Husáková, and Jirí Kunes, and Vera Klimesová, and Karel Palát, and Jarmila Kaustová
January 2000, European journal of medicinal chemistry,
Karel Waisser, and Josef Matyk, and Hana Divisová, and Petra Husáková, and Jirí Kunes, and Vera Klimesová, and Karel Palát, and Jarmila Kaustová
January 1998, Archiv der Pharmazie,
Karel Waisser, and Josef Matyk, and Hana Divisová, and Petra Husáková, and Jirí Kunes, and Vera Klimesová, and Karel Palát, and Jarmila Kaustová
August 2000, Arzneimittel-Forschung,
Karel Waisser, and Josef Matyk, and Hana Divisová, and Petra Husáková, and Jirí Kunes, and Vera Klimesová, and Karel Palát, and Jarmila Kaustová
December 1990, Bollettino della Societa italiana di biologia sperimentale,
Copied contents to your clipboard!